Literature DB >> 21649799

Clinical outcomes and patient satisfaction following total joint replacement in haemophilia--23-year experience in knees, hips and elbows.

K Wang1, A Street, A Dowrick, S Liew.   

Abstract

Joint replacement surgery is an available option for end-stage haemophilic arthropathy. However, reports with long-term follow-up are limited. Moreover, patient satisfaction in this setting has never been measured. We share our institution's experience with joint arthroplasty in haemophilic arthropathy and report on clinical outcomes and patient satisfaction. Between 1985 and 2007, 65 consecutive joints in 45 patients (mean age: 48.6; range: 22-83) underwent joint replacement surgery. Of these, 40 total knee replacements in 31 patients, 18 total hip replacements in 16 patients and 6 total elbow replacements in 3 patients were included. Average follow-up was 10.7 years (2.4-24.3). Charts were reviewed retrospectively and patients were asked to return for clinical assessment and completion of questionnaires. According to the Knee Society clinical score, postoperative results were good to excellent in 83% of knees. According to the Harris Hip Score, results were good to excellent in 31% of hips. According to the Mayo Elbow Performance Score, results were good to excellent in 83% of elbows. Complication rates are higher than in the non-haemophilic population, while prosthesis survival rates are lower. Patient satisfaction with pain relief is higher than satisfaction with functional improvement. For 88% of joints, patients are willing to have the same operation again. This study confirms previous knowledge on the role of total joint arthroplasty in haemophilic arthropathy. Despite high complication rates and modest functional outcomes, the operations are valuable for achieving pain relief. In general, patients find that risks are outweighed by the benefits.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21649799     DOI: 10.1111/j.1365-2516.2011.02579.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  8 in total

1.  Total Hip Arthroplasty in Hemophilia Patients: A Mid-term to Long-term Follow-up.

Authors:  Guo-Liang Wu; Ji-Liang Zhai; Bin Feng; Yan-Yan Bian; Chi Xu; Xi-Sheng Weng
Journal:  Orthop Surg       Date:  2017-11       Impact factor: 2.071

2.  Long-term results of total knee arthroplasty in haemophilic patients: an 18-year follow-up.

Authors:  Lukas Ernstbrunner; Andreas Hingsammer; Sabrina Catanzaro; Reto Sutter; Brigit Brand; Karl Wieser; Sandro F Fucentese
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-11-03       Impact factor: 4.342

3.  Total hip arthroplasty in patients with haemophilia - What are the risks of bleeding in the immediate peri-operative period?

Authors:  Grainne Colgan; Joseph F Baker; N Donlon; N Hogan; T McCarthy
Journal:  J Orthop       Date:  2016-07-27

4.  Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases.

Authors:  Toshiyuki Tateiwa; Yasuhito Takahashi; Tsunehito Ishida; Kosuke Kubo; Toshinori Masaoka; Takaaki Shishido; Keiji Sano; Kengo Yamamoto
Journal:  Ther Clin Risk Manag       Date:  2015-09-15       Impact factor: 2.423

5.  Revision Knee Arthroplasty in Patients with Inherited Bleeding Disorders: A Single-Center Experience.

Authors:  Andrzej Kotela; Magdalena Wilk-Frańczuk; Piotr Żbikowski; Paweł Łęgosz; Paweł Ambroziak; Ireneusz Kotela
Journal:  Med Sci Monit       Date:  2017-01-09

Review 6.  The role of orthopaedic surgery in haemophilia: current rationale, indications and results.

Authors:  E Carlos Rodríguez-Merchán
Journal:  EFORT Open Rev       Date:  2019-05-10

Review 7.  Patient satisfaction and total hip arthroplasty: a review.

Authors:  Lauren Okafor; Antonia F Chen
Journal:  Arthroplasty       Date:  2019-09-02

8.  Successful management of total knee replacement in a high responder hemophilia patient with a history of inhibitor.

Authors:  Roya Dolatkhah; Mohammad Reza Bazavar; Masoud Poureisa; Iraj Asvadi Kermani; Jalil Vaez Gharamaleki; Zohreh Sanaat; Jamal Eivazi Ziaei; Alireza Nikanfar; Ali Esfahani; Seyed Hadi Chavoshi
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.